Skip to main content
Log in

Anti-Tumor-Impfung bei HNO-Tumoren

Dem Erfolg auf der Spur

Antitumour vaccination in patients with ENT tumours

Moving towards success!

  • Im Fokus
  • Published:
HNO Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Bernier J, Domenge C, Ozsahin M et al. (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19): 1945–1952

    Google Scholar 

  2. Bier H, Armonat G, Schirrmacher V, Ganzer U (1989) Postoperative active-specific immunotherapy of lymphnode micrometastasis in a guinea pig tumor model. ORL J Otorhinolaryngol Relat Spec 51: 197–205

    Google Scholar 

  3. Gotte K, Usener D, Riedel F, Hormann K, Schadendorf D, Eichmuller S (2002) Tumor-associated antigens as possible targets for immune therapy in head and neck cancer: comparative mRNA analysis of RAGE and GAGE genes. Acta Otolaryngol 122(5): 546–552

    Google Scholar 

  4. Heimdal JH, Aarstad HJ, Klementsen B, Olofsson J (1999) Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis. Acta Otolaryngol 119: 281–284

    Article  CAS  PubMed  Google Scholar 

  5. Karcher J, Dyckhoff G, Beckhove P et al. (2004) Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells. Cancer Res 64: 8057–8061

    Google Scholar 

  6. Qin H, Valentino J, Manna S et al. (2001) Gene therapy for head and neck cancer using vaccinia virus expressing IL-2 in a murine model, with evidence of immune suppression. Mol Ther 4: 551–558

    Google Scholar 

  7. Schirrmacher V, Ahlert T, Proebstle T et al. (1998) Immunization with virus-modified tumor cells. Semin Oncol 25: 677–696

    CAS  PubMed  Google Scholar 

  8. Thomas GR, Chen Z, Enamorado I, Bancroft C, Van Waes (2000) IL-12- and IL-2-induced tumor regression in a new murine model of oral squamous-cell carcinoma is promoted by expression of the CD80 co-stimulatory molecule and interferon-gamma. Int J Cancer 86: 368–374

    Google Scholar 

  9. Tisch M, Heimlich F, Daniel V, Opelz G, Maier H (1998) Cellular immune defect caused by postsurgical radiation therapy in patients with head and neck cancer. Otolaryngol Head Neck Surg 119: 412–417

    Google Scholar 

  10. Young MR, Lathers DM (1999) Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers. Int J Immunopharmacol 21: 241–252

    Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Dyckhoff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dyckhoff, G., Herold-Mende, C. Anti-Tumor-Impfung bei HNO-Tumoren. HNO 53, 209–212 (2005). https://doi.org/10.1007/s00106-005-1226-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00106-005-1226-1

Navigation